ENCELTO™ for Macular Telangiectasia Type 2 (MacTel)
The U.S. Food and Drug Administration (FDA) has approved ENCELTO™ (revakinagene taroretcel-lwey), the first and only treatment for Macular Telangiectasia Type 2 (MacTel). Understanding MacTel: [...]
